Progression of heart failure: a role for interstitial fibrosis

H N Sabbah1, V G Sharov, M Lesch

  • 1Department of Medicine, Henry Ford Heart and Vascular Institute, Detroit, Michigan, USA.

Insights

Heart failure (HF) involves worsening left ventricular (LV) function. Collagen buildup in HF reduces capillary density and increases oxygen diffusion distance, potentially causing myocyte hypoxia and dysfunction.

Area of Science:

  • Cardiovascular Science
  • Cardiac Pathophysiology
  • Heart Failure Research

Background:

  • Progressive left ventricular (LV) dysfunction characterizes heart failure (HF).
  • Mechanisms of hemodynamic deterioration in HF remain unclear, possibly involving cardiocyte loss.
  • Reactive interstitial fibrosis (RIF) is a known feature of HF.

Purpose of the Study:

  • To test if RIF in HF reduces capillary density (CD) and increases oxygen diffusion distance (ODD).
  • To investigate if RIF-induced changes lead to myocyte hypoxia and dysfunction.
  • To evaluate the relationship between RIF, CD, and ODD in chronic canine HF.

Main Methods:

  • Studied LV tissue from 10 dogs with chronic HF (ejection fraction 26 ± 1%).
  • HF was induced by sequential intracoronary microembolizations.
  • Assessed CD (capillary/fiber ratio) and ODD in regions with severe RIF vs. minimal RIF.

Main Results:

  • Severe RIF regions showed significantly decreased capillary density (0.92 ± 0.02 vs. 1.05 ± 0.03).
  • Severe RIF regions exhibited significantly increased oxygen diffusion distance (15.3 ± 0.4 vs. 12.2 ± 0.3 microns).
  • These changes were statistically significant (P < 0.003 for CD, P < 0.001 for ODD).

Conclusions:

  • In chronic canine HF, severe RIF is associated with reduced capillary density and increased oxygen diffusion distance.
  • These RIF-induced microvascular changes suggest myocytes in fibrotic regions may experience chronic hypoxia.
  • Hypoxia in collagen-encircled myocytes could adversely affect their function and viability in heart failure.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.